Interest Expense in USD of REGENERX BIOPHARMACEUTICALS INC from 2011 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
REGENERX BIOPHARMACEUTICALS INC quarterly/annual Interest Expense history and change rate from 2011 to Q1 2023.
  • REGENERX BIOPHARMACEUTICALS INC Interest Expense for the quarter ending 31 Mar 2023 was $80.3K, unchanged year-over-year.
  • REGENERX BIOPHARMACEUTICALS INC Interest Expense for the twelve months ending 31 Mar 2023 was $326K, a 0.24% increase year-over-year.
  • REGENERX BIOPHARMACEUTICALS INC annual Interest Expense for 2022 was $326K, a 0.24% increase from 2021.
  • REGENERX BIOPHARMACEUTICALS INC annual Interest Expense for 2021 was $325K, a 39.7% increase from 2020.
  • REGENERX BIOPHARMACEUTICALS INC annual Interest Expense for 2020 was $233K, a 51.6% increase from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

REGENERX BIOPHARMACEUTICALS INC Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $326K $80.3K $0 0% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023
Q4 2022 $326K $82.1K +$1.00 +0% 01 Oct 2022 31 Dec 2022 10-K 11 Apr 2023
Q3 2022 $326K $82.1K +$769 +0.95% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2022
Q2 2022 $325K $81.2K -$1 0% 01 Apr 2022 30 Jun 2022 10-Q 12 Aug 2022
Q1 2022 $325K $80.3K $0 0% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 $325K $82.1K +$4.87K +6.31% 01 Oct 2021 31 Dec 2021 10-K 11 Apr 2023
Q3 2021 $320K $81.3K +$29.1K +55.8% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 $291K $81.2K +$29.6K +57.3% 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2022
Q1 2021 $261K $80.3K +$28.7K +55.6% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022
Q4 2020 $233K $77.2K +$25K +47.9% 01 Oct 2020 31 Dec 2020 10-K 30 Mar 2022
Q3 2020 $208K $52.2K $0 0% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021
Q2 2020 $208K $51.6K +$12.2K +30.9% 01 Apr 2020 30 Jun 2020 10-Q 06 Aug 2021
Q1 2020 $195K $51.6K +$42K +438% 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021
Q4 2019 $153K $52.2K +$48.2K +1202% 01 Oct 2019 31 Dec 2019 10-K 02 Mar 2021
Q3 2019 $105K $52.2K +$33.5K +179% 01 Jul 2019 30 Sep 2019 10-Q 13 Nov 2020
Q2 2019 $71.7K $39.4K +$13.7K +53.1% 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020
Q1 2019 $58K $9.59K -$29.2K -75.3% 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020
Q4 2018 $87.3K $4.01K -$37.6K -90.4% 01 Oct 2018 31 Dec 2018 10-K 20 Mar 2020
Q3 2018 $125K $18.7K -$24.9K -57.1% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019
Q2 2018 $150K $25.8K -$17.3K -40.2% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019
Q1 2018 $167K $38.8K -$3.8K -8.92% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019
Q4 2017 $171K $41.6K -$2K -4.59% 01 Oct 2017 31 Dec 2017 10-K 29 Mar 2019
Q3 2017 $173K $43.6K -$1 0% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 $173K $43.1K -$1 0% 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018
Q1 2017 $173K $42.6K -$472 -1.1% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018
Q4 2016 $173K $43.6K -$1 0% 01 Oct 2016 31 Dec 2016 10-K 29 Mar 2018
Q3 2016 $173K $43.6K +$1.00 +0% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017
Q2 2016 $173K $43.1K $0 0% 01 Apr 2016 30 Jun 2016 10-Q 21 Aug 2017
Q1 2016 $173K $43.1K +$472 +1.11% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017
Q4 2015 $173K $43.6K -$720 -1.63% 01 Oct 2015 31 Dec 2015 10-K 29 Mar 2017
Q3 2015 $174K $43.6K -$3.42K -7.27% 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016
Q2 2015 $177K $43.1K -$3.38K -7.27% 01 Apr 2015 30 Jun 2015 10-Q 22 Aug 2016
Q1 2015 $180K $42.6K -$3.08K -6.73% 01 Jan 2015 31 Mar 2015 10-Q 16 May 2016
Q4 2014 $183K $44.3K +$772 +1.77% 01 Oct 2014 31 Dec 2014 10-K 11 Apr 2016
Q3 2014 $183K $47K +$17.8K +61.1% 01 Jul 2014 30 Sep 2014 10-Q 13 Nov 2015
Q2 2014 $165K $46.5K +$25.3K +119% 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2015
Q1 2014 $140K $45.7K +$38.7K +549% 01 Jan 2014 31 Mar 2014 10-Q 15 May 2015
Q4 2013 $101K $43.5K +$37.8K +664% 01 Oct 2013 31 Dec 2013 10-K 31 Mar 2015
Q3 2013 $63.1K $29.2K +$29.2K 01 Jul 2013 30 Sep 2013 10-Q 10 Nov 2014
Q2 2013 $33.9K $21.2K +$21.2K 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014
Q1 2013 $12.7K $7.04K +$7.04K 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014
Q4 2012 $5.7K $5.7K 01 Oct 2012 31 Dec 2012 10-K 04 Apr 2014
Q3 2012 $0 01 Jul 2012 30 Sep 2012 10-Q 18 Nov 2013
Q2 2012 $0 01 Apr 2012 30 Jun 2012 10-Q 14 Aug 2013
Q1 2012 $0 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013

REGENERX BIOPHARMACEUTICALS INC Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $326K +$769 +0.24% 01 Jan 2022 31 Dec 2022 10-K 11 Apr 2023
2021 $325K +$92.2K +39.7% 01 Jan 2021 31 Dec 2021 10-K 11 Apr 2023
2020 $233K +$79.2K +51.6% 01 Jan 2020 31 Dec 2020 10-K 30 Mar 2022
2019 $153K +$66.1K +75.8% 01 Jan 2019 31 Dec 2019 10-K 02 Mar 2021
2018 $87.3K -$83.6K -48.9% 01 Jan 2018 31 Dec 2018 10-K 20 Mar 2020
2017 $171K -$2.47K -1.43% 01 Jan 2017 31 Dec 2017 10-K 29 Mar 2019
2016 $173K +$472 +0.27% 01 Jan 2016 31 Dec 2016 10-K 29 Mar 2018
2015 $173K -$10.6K -5.77% 01 Jan 2015 31 Dec 2015 10-K 29 Mar 2017
2014 $183K +$82.5K +81.8% 01 Jan 2014 31 Dec 2014 10-K 11 Apr 2016
2013 $101K +$95.2K +1672% 01 Jan 2013 31 Dec 2013 10-K 31 Mar 2015
2012 $5.7K +$5.7K 01 Jan 2012 31 Dec 2012 10-K 04 Apr 2014
2011 $0 01 Jan 2011 31 Dec 2011 10-K 16 Apr 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.